• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期识别镰状细胞病儿科患者自我管理行为的障碍和促进因素,以尽量减少造血细胞移植并发症。

Early Identification of Barriers and Facilitators to Self-Management Behaviors in Pediatric Patients With Sickle Cell Disease to Minimize Hematopoietic Cell Transplantation Complications.

作者信息

Schulz Ginny L, Foster Rebecca H, Kennedy Lang Valerie, Towerman Alison, Shenoy Shalini, Lauer Brea-Anne, Molzon Elizabeth, Holtmann Megan

机构信息

1 St. Louis Children's Hospital, St. Louis, MO, USA.

2 Washington University School of Medicine, St. Louis, MO, USA.

出版信息

J Pediatr Oncol Nurs. 2018 May;35(3):199-209. doi: 10.1177/1043454218762703. Epub 2018 Mar 26.

DOI:10.1177/1043454218762703
PMID:29577801
Abstract

Hematopoietic cell transplantation (HCT) is an elective, curative treatment option for patients with sickle cell disease (SCD). Transplant requires extensive self-management behaviors to be successful. The purpose of this study was to describe potential barriers and facilitators to self-management in a group of pediatric patients with SCD prior to HCT and their medical outcomes post-HCT. A multiple case study approach was used to describe 4 pairs of transplant recipients grouped by age, donor type, and donor source. Each pair included a case with minimal and increased post-HCT complications. Complications included readmissions, graft-versus-host disease, systemic infections, and survival in the first year post-HCT. Variables were retrospectively collected and content analyzed to identify barriers and facilitators within and across pairs using existing self-management frameworks. While higher risk transplants experienced more complications, 3 of the 4 cases with increased complications had a larger number of modifiable barriers identified compared with those experiencing minimal complications. At least one modifiable barrier and multiple facilitators were identified in all cases. A standardized psychosocial assessment process with an established plan to mitigate barriers and promote facilitators to self-management is essential to optimize outcomes in patients with SCD undergoing elective HCT.

摘要

造血细胞移植(HCT)是镰状细胞病(SCD)患者的一种选择性根治性治疗方案。移植要取得成功需要广泛的自我管理行为。本研究的目的是描述一组小儿SCD患者在HCT前自我管理的潜在障碍和促进因素,以及他们HCT后的医疗结局。采用多案例研究方法描述了4对按年龄、供体类型和供体来源分组的移植受者。每对包括一个HCT后并发症最少和增加的病例。并发症包括再次入院、移植物抗宿主病、全身感染以及HCT后第一年的生存率。回顾性收集变量并进行内容分析,以使用现有的自我管理框架识别各对病例内部和之间的障碍和促进因素。虽然高风险移植出现更多并发症,但4例并发症增加的病例中有3例与并发症最少的病例相比,可改变的障碍数量更多。所有病例均至少识别出一个可改变的障碍和多个促进因素。对于接受选择性HCT的SCD患者,一个标准化的社会心理评估过程以及一个既定的减轻障碍和促进自我管理促进因素的计划对于优化结局至关重要。

相似文献

1
Early Identification of Barriers and Facilitators to Self-Management Behaviors in Pediatric Patients With Sickle Cell Disease to Minimize Hematopoietic Cell Transplantation Complications.早期识别镰状细胞病儿科患者自我管理行为的障碍和促进因素,以尽量减少造血细胞移植并发症。
J Pediatr Oncol Nurs. 2018 May;35(3):199-209. doi: 10.1177/1043454218762703. Epub 2018 Mar 26.
2
Dermatologic complications in pediatric patients after hematopoietic stem cell transplantation for sickle cell disease.小儿血液干细胞移植治疗镰状细胞病后的皮肤并发症。
Pediatr Dermatol. 2024 Jan-Feb;41(1):61-65. doi: 10.1111/pde.15471. Epub 2023 Nov 15.
3
Outcomes of Unrelated Donor Stem Cell Transplantion with Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients with Severe Sickle Cell Disease.异基因造血干细胞移植后应用环磷酰胺预防严重镰状细胞病患者移植物抗宿主病的结果。
Biol Blood Marrow Transplant. 2018 Feb;24(2):413-417. doi: 10.1016/j.bbmt.2017.10.030. Epub 2017 Oct 20.
4
Bone marrow transplantation in sickle cell anemia.镰状细胞贫血的骨髓移植
Curr Opin Oncol. 2001 Mar;13(2):85-90. doi: 10.1097/00001622-200103000-00001.
5
Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation.父母对接受造血干细胞移植的镰状细胞病患儿和青少年的不孕风险及生育力保存选择的看法。
Pediatr Blood Cancer. 2023 Jul;70(7):e30276. doi: 10.1002/pbc.30276. Epub 2023 Apr 13.
6
Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.造血细胞移植后镰状细胞病儿科和青少年患者的生殖健康评估和生育咨询报告。
Transplant Cell Ther. 2024 Sep;30(9):912.e1-912.e13. doi: 10.1016/j.jtct.2024.06.029. Epub 2024 Jul 5.
7
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.镰状细胞病和地中海贫血患儿造血干细胞移植后期效应的当前结果及未来研究重点:第二届儿科血液和骨髓移植联盟国际儿科造血干细胞移植后期效应会议的共识声明
Biol Blood Marrow Transplant. 2017 Apr;23(4):552-561. doi: 10.1016/j.bbmt.2017.01.009. Epub 2017 Jan 5.
8
Improved Quality of Life of Patients With Sickle Cell Disease after Allogeneic Stem Cell Transplant: Another Indication for Transplant.异基因干细胞移植后镰状细胞病患者生活质量改善:移植的另一指征
Hematol Oncol Stem Cell Ther. 2023 Jul 20;17(1):37-42. doi: 10.56875/2589-0646.1107.
9
Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.《在接受减强度无关供者移植治疗严重镰状细胞病后的脑功能和影像学评估:血液和骨髓移植临床试验网络研究 0601》。
Biol Blood Marrow Transplant. 2019 May;25(5):e174-e178. doi: 10.1016/j.bbmt.2019.01.008. Epub 2019 Jan 11.
10
Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.镰状细胞病异基因造血干细胞移植后的健康相关生活质量
Biol Blood Marrow Transplant. 2015 Apr;21(4):666-72. doi: 10.1016/j.bbmt.2014.12.007. Epub 2015 Jan 2.

引用本文的文献

1
Balancing benefits and burdens: a systematic review on ethical and social dimensions of gene and cell therapies for hereditary blood diseases.权衡利弊:关于遗传性血液疾病基因和细胞疗法伦理与社会层面的系统评价
BMC Med Ethics. 2025 Mar 14;26(1):36. doi: 10.1186/s12910-025-01188-3.
2
A Needs Assessment of Persons With Sickle Cell Disease in a Major Medical Center in North Carolina.北卡罗来纳州一家主要医疗中心镰状细胞病患者需求评估。
N C Med J. 2021 Sep-Oct;82(5):312-320. doi: 10.18043/ncm.82.5.312.